Skip to main content
. Author manuscript; available in PMC: 2016 Jan 16.
Published in final edited form as: J Cutan Pathol. 2015 Sep 2;42(11):807–814. doi: 10.1111/cup.12564

Fig. 1.

Fig. 1

Representative photomicrographs showing 5-hydroxymethycytosine (5-hmC) immunolabeling in a melanocytic nevus (A–C), markedly decreased 5-hmC expression in a primary melanoma (D–F). 5-hmC nuclear labeling is also observed in background normal cells including keratinocytes and lymphocytes (not shown). Panels A and D at ×100; B, C, E, and F at 400×, original magnification.